Search For "sars cov"
India well-equipped to swiftly detect, contain new COVID variants: Ex-ICMR
Updated : 9 months, 1 week ago IST
As of Tuesday morning, India has reported 6,815 active COVID-19 cases. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), 163 cases of the new COVID-19 variant XFG have recently been detected across the country.
Read More
New mRNA vaccine is more effective, less costly to develop: Study
Updated : 5 months, 1 week ago IST
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University.
Read More
IIT Guwahati harnesses clay sedimentation to identify and measure Coronavi
Updated : 9 months, 1 week ago IST
Indian Institute of Technology Guwahati researchers have developed a novel method for detecting and measuring the amount of SARS-CoV-2, the virus that causes COVID-19. The innovative approach is based on how quickly a clay-virus-electrolyte mixture settles; a process commonly known as sedime
Read More
"We are going to see more outbreaks like monkeypox or zika virus in coming
Updated : 1 year, 6 months ago IST
Chairman of the Institute of Internal Medicine Respiratory and Sleep Medicine at Medanta and Former AIIMS director Dr Randeep Guleria on Thursday stated that India is one of the high-burden countries as far as tuberculosis is concerned and a lot of measures have been taken in the private and
Read More
Vaping can enhance vulnerability to infection with SARS-CoV-2: Study
Updated : 2 years ago IST
According to a study, vapers are susceptible to infection by SARS-CoV-2, the virus that causes COVID-19 and continues to infect people all over the world.
Read More
CrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Samples
Updated : 2 years, 1 month ago IST
Bengaluru (Karnataka) [India], February 7: Bengaluru-based startup CrisprBits Private Limited, has developed OmiCrisp, a CRISPR based testing platform for rapid diagnosis and surveillance of SARS-CoV2. The CRISPR based test not only detects the virus, but also distinguishes variants of Omicr
Read More
Telangana reports eight new COVID cases
Updated : 2 years, 2 months ago IST
Eight new COVID cases were reported in Telangana on Tuesday by the Government of Telangana, Office of the Director of Public Health and Family Welfare. A total of 59 cases are under treatment.
Read More
Covid subvariant JN.1: No need for additional dose of vaccine at present,
Updated : 2 years, 2 months ago IST
Amid a surge in COVID cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is required against the subvariant at the present stage.
Read More
Covid subvariant JN.1 in Kerala: Union Health Ministry initiates preparedn
Updated : 2 years, 2 months ago IST
The Union Ministry of Health has initiated preparedness measures after a case of the JN.1 subvariant of COVID has been identified in Kerala as part of the ongoing routine surveillance conducted by the Indian SARS-CoV-2 Genomics Consortium (INSACOG), said a government release on Saturday.
Read More
Covid subvariant JN.1 case detected in Kerala, raises concerns
Updated : 2 years, 2 months ago IST
The India SARS-CoV-2 Genomics Consortium (INSACOG), which is a multi-laboratory, multi-agency, pan-India network tasked with sequencing and keeping an eye on new threatening Covid-19 variants, has done surveillance where this variant has been found in Kerala.
Read More
Vaccine that offers protection against three deadly coronavirus types has
Updated : 2 years, 4 months ago IST
A vaccine developed by Duke Human Vaccine Institute researchers that protects against three distinct fatal coronaviruses has shown success in animal studies, indicating the potential for pan-coronavirus immunisation.
Read More
Single vaccine that protects against three lethal coronavirus types succes
Updated : 5 months, 1 week ago IST
A vaccine created by researchers at the Duke Human Vaccine Institute that protects against three separate lethal coronaviruses has shown success in mouse trials, suggesting the potential of a pan-coronavirus vaccination.
Read More